Timing of metabolomics-driven supplementation strategies affects protein expression in E. coli-based cell-free expression systems

Abstract

While in vivo synthesis of biologic therapeutics has been broadly successful, it is limited by biological constraints of the cells and by the complexity, time, and cost of implementing the pipeline from discovery through manufacturing. Cell-free expression systems (CFES), which use cellular transcription and translation machinery to express proteins in vitro, offer a promising alternative approach that could improve robustness and modularity in that pipeline. However, current benchmark CFES productivity is well below the theoretical capacity of the input nucleotides and amino acids. Efforts to address this issue are hindered by limited understanding of the extent of enzymatic activity in CFES beyond gene expression, as previous work has shown that metabolic enzymes in cell-free lysates cause substantial background metabolic activity that influences protein expression. Here, we hypothesized that the inflection point of protein expression is a critical timescale for CFES metabolism. We performed metabolomics characterization of CFES reactions, finding significant metabolic changes at the inflection point. Driven by these findings, we sought to identify supplements that could be added to the cell-free reaction to avoid metabolic limitations. We found that amino acid supplementation increased expression productivity and lifetime only when added after the inflection point, and actually hurt expression when added before the inflection point. We found similar supplementation timing impacts for some other metabolites as well. These findings show that endogenous metabolism and supplementation timing are deeply interconnected and are critical considerations in CFES optimization, and that metabolomics-informed fed-batch supplementation is a potentially valuable strategy to improve reaction productivity.